About Donald Kiepert
Form D filings for Reiley Pharmaceuticals in 2024 list Donald Kiepert as CEO and director.
Donald Kiepert first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Donald Kiepert in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Donald Kiepert works with at each company, as listed on that company's latest Form D.
Reiley Pharmaceuticals, Inc. · Form D, Jun 5, 2024